Vigilant Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ecolab
ECL
|
+$18.1M |
| 2 |
Goldman Sachs
GS
|
+$15.5M |
| 3 |
10x Genomics
TXG
|
+$9.95M |
| 4 |
Visa
V
|
+$2.59M |
| 5 |
Abbott
ABT
|
+$2.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.4M |
| 2 |
TSMC
TSM
|
+$4.57M |
| 3 |
Apple
AAPL
|
+$3.01M |
| 4 |
FRC
First Republic Bank
FRC
|
+$2.68M |
| 5 |
NXP Semiconductors
NXPI
|
+$2.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.2% |
| 2 | Healthcare | 15.54% |
| 3 | Financials | 11.49% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 10.44% |
Similar funds
Vigilant Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Vigilant Capital Management held 395 positions worth $1.12B, up 7.7% from $1.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Vigilant Capital Management deployed $43.6M of net new capital in Q1 2021, opening 66 new positions and adding to 74 existing holdings. Its largest new stake was 10x Genomics: 57,590 shares worth $10.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $8.4M trimmed.
- Vigilant Capital Management's largest Q1 2021 buy was 10x Genomics: 57,590 shares worth $10.4M.
- Vigilant Capital Management added most to Ecolab in Q1 2021, an estimated $18.1M increase.
- Vigilant Capital Management's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $8.4M.
- Vigilant Capital Management fully exited iShares Core Universal USD Bond ETF in Q1 2021, selling an estimated $682K.
- Vigilant Capital Management's ten largest holdings make up 30% of its $1.12B portfolio in Q1 2021.
- Vigilant Capital Management opened 66 new positions and closed 39 in Q1 2021.
- Vigilant Capital Management's portfolio value rose 7.7% quarter-over-quarter to $1.12B.
Based on Vigilant Capital Management's 13F filing for Q1 2021, filed 16 Apr 2021.